A strategy to design protein-based antagonists against type I cytokine receptors.
Saved in:
| Title: | A strategy to design protein-based antagonists against type I cytokine receptors. |
|---|---|
| Authors: | Ullrich T; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany., Klimenkova O; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Pollmann C; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany., Lasram A; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany., Hatskovska V; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Maksymenko K; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany., Milijaš-Jotić M; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany., Schenk L; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Lengerke C; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Hartmann MD; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany., Piehler J; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany., Skokowa J; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., ElGamacy M; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany. |
| Source: | PLoS biology [PLoS Biol] 2024 Nov 26; Vol. 22 (11), pp. e3002883. Date of Electronic Publication: 2024 Nov 26 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39591631 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A strategy to design protein-based antagonists against type I cytokine receptors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ullrich+T%22">Ullrich T</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Klimenkova+O%22">Klimenkova O</searchLink>; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Pollmann+C%22">Pollmann C</searchLink>; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.<br /><searchLink fieldCode="AU" term="%22Lasram+A%22">Lasram A</searchLink>; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.<br /><searchLink fieldCode="AU" term="%22Hatskovska+V%22">Hatskovska V</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Maksymenko+K%22">Maksymenko K</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Milijaš-Jotić+M%22">Milijaš-Jotić M</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schenk+L%22">Schenk L</searchLink>; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lengerke+C%22">Lengerke C</searchLink>; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+MD%22">Hartmann MD</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Piehler+J%22">Piehler J</searchLink>; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.<br /><searchLink fieldCode="AU" term="%22Skokowa+J%22">Skokowa J</searchLink>; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22ElGamacy+M%22">ElGamacy M</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101183755%22">PLoS biology</searchLink> [PLoS Biol] 2024 Nov 26; Vol. 22 (11), pp. e3002883. <i>Date of Electronic Publication: </i>2024 Nov 26 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101183755 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1545-7885 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215449173%22">15449173 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39591631 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pbio.3002883 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e3002883 Titles: – TitleFull: A strategy to design protein-based antagonists against type I cytokine receptors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ullrich T – PersonEntity: Name: NameFull: Klimenkova O – PersonEntity: Name: NameFull: Pollmann C – PersonEntity: Name: NameFull: Lasram A – PersonEntity: Name: NameFull: Hatskovska V – PersonEntity: Name: NameFull: Maksymenko K – PersonEntity: Name: NameFull: Milijaš-Jotić M – PersonEntity: Name: NameFull: Schenk L – PersonEntity: Name: NameFull: Lengerke C – PersonEntity: Name: NameFull: Hartmann MD – PersonEntity: Name: NameFull: Piehler J – PersonEntity: Name: NameFull: Skokowa J – PersonEntity: Name: NameFull: ElGamacy M IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 11 Text: 2024 Nov 26 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1545-7885 Numbering: – Type: volume Value: 22 – Type: issue Value: 11 Titles: – TitleFull: PLoS biology Type: main |
| ResultId | 1 |